MedTrace Logo

Seroprevalence of COVID-19

NCT04941053 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-10-25

No results posted yet for this study

Summary

Coronavirus disease pandemic has been started in late 2019. Since this date, the number of cases has been increased reaching 32.7 million cases worldwide in 27 September, 2020. . Herd immunity is achieved when enough people become immune to a virus to stop its spread. Around 70% to 90% of a population needs to be immune to protect the uninfected. In A Spanish study of more than 30,000 people estimates that around just 5% of the Spanish population has developed antibodies

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

laboratory test

seroprevalnce

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • N S shafik, lecturer · Sohag University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-03
Primary Completion
2021-08-30
Completion
2021-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04941053 on ClinicalTrials.gov